Table 2.
CIS n = 31 | MS n = 48 | CIS/MS n = 31/n = 48 | Controls n = 30 | p-Value | |
---|---|---|---|---|---|
Gd+ CIS/MS n = 13/n = 34 | 440.3 (240.9–482.7) | 343.0 (267.1–537.0) | 344.1 (264.5–531.8) | n.s.a | |
Gd– CIS/MS n = 18/n = 14 | 347.0 (290.4–429.8) | 292.1 (269.0–467.5) | 316.1 (279.4–438.5) | n.s.a | |
All
|
376.0 (280.0–471.1) |
335.8 (268.0–512.3) |
342.4 (272.8–482.7) |
404.5 (273.9–550.1) |
n.s.b |
p-Value | n.s.a | n.s.a | n.s.a |
Gd+: gadolinium-positive; Gd–: gadolinium-negative; n: number of subjects; n.s.: not significant.
Values are given in pg/ml as median (interquartile range). Significance (p < 0.05) was assessed between subgroups by Mann–Whitney U testa or Kruskal–Wallis test.b